EcoDrugPlus

Ribosomal Protein L34

Ensembl ID : ENSHBUG00000019460
Gene Symbol: RPL34
3 Cross references
362 Possible Orthologues:

Ribosomal Protein L35

Ensembl ID : ENSHBUG00000003110
Gene Symbol: RPL35
3 Cross references
274 Possible Orthologues:

Ribosomal Protein L35a

Ensembl ID : ENSHBUG00000016737
Gene Symbol: RPL35A
3 Cross references
452 Possible Orthologues:

Ribosomal Protein L36

Ensembl ID : ENSHBUG00000002097
Gene Symbol: RPL36
3 Cross references
400 Possible Orthologues:

Ribosomal Protein L37

Ensembl ID : ENSHBUG00000007271
Gene Symbol: RPL37
3 Cross references
424 Possible Orthologues:

Ribosomal Protein L37a

Ensembl ID : ENSHBUG00000022542
Gene Symbol: RPL37A
4 Cross references
420 Possible Orthologues:

Ribosomal Protein L39

Ensembl ID : ENSHBUG00000017410
Gene Symbol: RPL39
1 Cross references
146 Possible Orthologues:

Ribosomal Protein L4

Ensembl ID : ENSHBUG00000012721
Gene Symbol: RPL4
3 Cross references
341 Possible Orthologues:

Ribosomal Protein L5

Ensembl ID : ENSHBUG00000007423
Gene Symbol: RPL5
4 Cross references
469 Possible Orthologues:

Ribosomal Protein L5

Ensembl ID : ENSHBUG00000011716
Gene Symbol: RPL5
3 Cross references
455 Possible Orthologues:

Ribosomal Protein L6

Ensembl ID : ENSHBUG00000013655
Gene Symbol: RPL6
3 Cross references
486 Possible Orthologues:

Ribosomal Protein L7

Ensembl ID : ENSHBUG00000001007
Gene Symbol: RPL7
3 Cross references
492 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).